Insider Trading April 8, 2026 07:52 PM

Exzeo CEO Paresh Patel Buys 2,000 Shares as Stock Recovers From Earlier Drop

Purchase increases Patel’s direct holdings; company reports in-line Q4 and full-year 2025 results

By Sofia Navarro XZO
Exzeo CEO Paresh Patel Buys 2,000 Shares as Stock Recovers From Earlier Drop
XZO

Exzeo Group CEO Paresh Patel acquired 2,000 shares of the company's common stock on April 7, 2026, spending $28,440 at $14.22 per share. The transaction raises his direct ownership to 1,602,013 shares. The purchase follows a 35% year-to-date decline in the stock that has since partially reversed, with shares trading at $15.83. Exzeo recently reported fourth-quarter and full-year 2025 results that met earnings expectations, recording diluted EPS of $0.25 and quarterly revenue of $53.32 million. Patel also holds options to buy 5,000,000 shares granted October 1, 2021, with an exercise price of $23 and vesting that began October 1, 2022 and continues quarterly. Analysts' price targets range from $25 to $27. InvestingPro subscribers reportedly have access to eight additional tips on XZO, including detailed financial metrics and Fair Value analysis. The company issued no other news, there were no updates on mergers or acquisitions, and analyst firms have not yet issued fresh upgrades or downgrades.

Key Points

  • CEO Paresh Patel purchased 2,000 shares of Exzeo Group on April 7, 2026 at $14.22 per share, spending $28,440.
  • After the purchase Patel directly holds 1,602,013 shares and also controls options to buy 5,000,000 shares granted October 1, 2021 with a $23 exercise price that vest quarterly beginning October 1, 2022 - this is relevant to potential future share supply.
  • Exzeo reported fourth-quarter and full-year 2025 results that met earnings expectations, with diluted EPS of $0.25 and quarterly revenue of $53.32 million; analysts have price targets between $25 and $27, and InvestingPro subscribers are said to have access to eight additional XZO tips including financial health metrics and Fair Value analysis.

Exzeo Group, Inc. (NASDAQ: XZO) Chief Executive Officer Paresh Patel reported a personal purchase of company common stock on April 7, 2026. Patel acquired 2,000 shares at $14.22 per share, for a total outlay of $28,440.

The transaction occurred after Exzeo’s shares had declined 35% on a year-to-date basis, a drop from which the stock has partially recovered; at the time of reporting shares were trading at $15.83.

Following the April 7 purchase, Patel directly owns 1,602,013 shares of Exzeo Group common stock. In addition to those shares, Patel holds option rights to purchase 5,000,000 shares that were granted October 1, 2021. Those options carry an exercise price of $23 and began vesting in installments on October 1, 2022, with further vesting scheduled on a quarterly basis.

On the corporate reporting front, Exzeo Group released its fourth-quarter and full-year 2025 financial results and met analysts' earnings expectations. The company recorded diluted earnings per share of $0.25 for the quarter and reported quarterly revenue of $53.32 million. The results were described as reflecting robust growth, and the earnings release prompted a positive reaction from investors.

Outside of the financial results, there were no announcements regarding mergers or acquisitions and the company did not provide additional news beyond the reported quarterly and full-year figures. Analyst firms have not posted any new upgrades or downgrades for Exzeo Group in the wake of the results.

Market analysts covering Exzeo have set price targets in a $25 to $27 range. For subscribers to InvestingPro, there are said to be eight additional exclusive insights available on XZO, which include detailed financial health metrics and a Fair Value analysis.


These disclosures of insider purchases, combined with the company’s recent in-line financial performance and the outstanding option position held by the CEO, provide concrete detail on executive exposure to the stock and potential future share issuance tied to option exercise. The company has not provided further commentary beyond the earnings announcement, and no analyst actions have been publicly recorded following the results.

Risks

  • Price volatility - the stock had fallen 35% year-to-date before a partial rebound to $15.83, indicating ongoing market volatility that affects equity investors and the broader equities market.
  • Option overhang - Patel’s outstanding options to buy 5,000,000 shares at a $23 exercise price could represent future share issuance pressure if exercised, which may affect supply-demand dynamics in the equity market.
  • Lack of fresh analyst action or corporate developments - no new analyst upgrades/downgrades or merger-and-acquisition updates were released, leaving uncertainty about near-term catalysts for the stock and investor sentiment.

More from Insider Trading

American Eagle Outfitters Director Completes $49,728 Stock Sale; Shares Show Mixed Recent Performance Apr 8, 2026 Slide Insurance CRO Sells Entire Direct Stake After Option Exercise Apr 8, 2026 American Eagle Director Disposes of ~2,900 Shares as Company Posts Solid Quarter, Analysts Remain Cautious Apr 8, 2026 Slide Insurance Director Sells More Than $1 Million in Stock Under 10b5-1 Plan Apr 8, 2026 Slide Insurance President Executes $663,573 Sale of SLDE Shares Under 10b5-1 Plan Apr 8, 2026